
    
      Despite no protocol-defined study stopping criteria being met, the sponsor decided to
      terminate enrollment after the phase 1 portion was complete and to not move into the phase 2
      portion of the study. This decision was made due to difficulty enrolling participants and was
      not due to any safety concerns.
    
  